Review: Aspirin cuts cancer rates
LONDON — Taking a small daily dose of aspirin can significantly reduce the risk of developing — or dying from — bowel, stomach and esophageal cancer, according to a large review of scientific studies.
Researchers who analyzed all available evidence from studies and clinical trials assessing benefits and harm found that taking aspirin for 10 years could cut bowel cancer cases by about 35 percent and deaths from the disease by 40 percent.
Rates of esophageal and stomach cancer were cut by 30 percent, and deaths from these cancers by 35 to 50 percent.
Professor Jack Cuzick, head of the center for cancer prevention at Queen Mary University of London, said the evidence showed that to reap the benefits of aspirin, people need to take a daily dose of 75 to 100 milligrams for at least five years and probably as long as 10 years between the ages of 50 and 65.
No benefit was seen while taking aspirin for the first three years, and death rates were reduced only after five years, he and his team reported in a review in the Annals of Oncology journal.
“Our study shows that if everyone aged between 50 and 65 started taking aspirin daily for at least 10 years, there would be a 9 percent reduction in the number of cancers, strokes and heart attacks overall in men, and around 7 percent in women,” Cuzick said in a statement about the research.
The researchers warned that taking aspirin long-term increases the risk of bleeding in the stomach: Among 60-year-olds who take daily aspirin for 10 years, the risk of digestive tract bleeding increases from 2.2 percent to 3.6 percent, and this could be life-threatening in a small proportion of people, they said.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Carnegie Mellon expert to school Congress on security
- Tribune-Review poll: Cable news rises as network news falls
- Most young Republicans back legal marijuana
- Lawmakers press Veterans Affairs for improved access to rural health care
- Monarch butterflies find milkweed supply dwindles
- Natural gas royalties lawsuit hinges on transaction date
- Dems keep blocking joint negotiations on immigration orders
- Several states in path of wintry blasts
- Inhofe reverses on transporation bill
- EPA ripped for evading request for information
- Israeli Prime Minister Netanyahu rejects Jewish House Democrats’ invitation